Health News

• Follow-up Avastin shown to benefit colon cancer patients June 3, 2012
  CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. […]
• Armed antibody delays spread of certain breast cancers June 3, 2012
  CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs. […]
• J&J hormone-blocking pill slows prostate cancer spread June 2, 2012
  CHICAGO (Reuters) - A trial of Johnson & Johnson's Zytiga in certain prostate cancer patients showed that it doubled the amount of time they lived without the disease getting worse, potentially offering new hope for patients who see their cancer return. […]
• Bristol immune drug shows promise in three cancers June 2, 2012
  CHICAGO (Reuters) - An experimental Bristol-Myers Squibb drug helped shrink tumors in patients with advanced melanoma, kidney and lung cancers in a preliminary trial, raising hopes for yet another drug that can wake up the immune system and train it to attack cancer cells. […]
• Hospitals fight drug scarcity, fear patients harmed June 2, 2012
  WASHINGTON (Reuters) - At the Henry Ford Hospital in Detroit, pharmacists are using old-fashioned paper spreadsheets to track their stock of drugs in short supply - a task that takes several hours each day. […]
• Avastin delays progression of ovarian cancer June 2, 2012
  CHICAGO (Reuters) - Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial. […]
• U.S., Norway pledge $150 million for maternal health June 2, 2012
  OSLO (Reuters) - The United States and Norway each pledged on Friday to give in the range of $75 million to help protect mothers during labor, delivery and the first 24 hours after birth. […]
• Walgreen, Express Scripts drop claims against each other June 1, 2012
  (Reuters) - Walgreen Co said on Friday that it and drug benefits manager Express Scripts Holding Co had dropped claims against each other stemming from a September 2011 lawsuit, but said the dismissals did not mean they were any closer to reaching a new deal. […]
• Do doctor-payment sunshine laws work? June 1, 2012
  NEW YORK (Reuters Health) - The mere passage of a law that requires drug companies to disclose how much money they pay doctors may not change physician prescribing practices, suggests a new study. […]
• Babies fed soy formula develop as well as others June 1, 2012
  NEW YORK (Reuters Health) - One-year-olds raised on breast milk, regular formula or soy formula seem to fare equally well in brain development, a new study suggests. […]